...
首页> 外文期刊>Japanese Journal of Pharmacology >Cytoprotective Effects of NC-1300 and Omeprazole on HCI·Ethanol-Induced Gastric Lesions in Rats
【24h】

Cytoprotective Effects of NC-1300 and Omeprazole on HCI·Ethanol-Induced Gastric Lesions in Rats

机译:NC-1300和奥美拉唑对HCI·乙醇诱导的大鼠胃损伤的细胞保护作用

获取原文
   

获取外文期刊封面封底 >>

       

摘要

References(21) Cited-By(46) NC-1300 (10-100 mg/kg), given p.o. at 0.5, 6, 12 or 24 hr before HCI·ethanol, dose-dependently protected the rat gastric mucosa. This protection was observed even when the gastric contents had been removed before application of HCl·ethanol. NC-1300 (30 mg/kg), given i.p., was without effect on lesion formation in a dose which potently inhibited gastric acid secretion in pylorusligated rats. Pretreatment with indomethacin (5 mg/kg, s.c.) resulted in no reduction in the protection by NC-1300, excluding the possible participation of endogenous prostaglandins in the protective mechanism. N-ethylmaleimide pretreatment (10 mg/kg, s.c.) slightly reduced the protective activity of NC-1300, suggesting the partial participation of endogenous sulfhydryl compounds in the NC-1300 protection. NC-1300 sulfide and mercaptobenzimidazole (compounds obtained after mixing NC-1300 with acidic solution) also dose-dependently protected against HCl·ethanol-induced lesions when given p.o. at 0.5 hr before HCl·ethanol. The protection was significant but was considerably reduced in contrast to NC-1300 when the compounds were given 12 hr beforehand. NC-1300 sulfone had no effect on lesion formation. Omeprazole (10, 30 mg/kg), given p.o., also dosedependently inhibited HCl-ethanol -induced lesions. However, the duration of protection was shorter than that seen with NC-1300, i.e., the effect disappeared 12 hr later. Thus, NC-1300 has a potent and long-lasting activity on HCl·ethanolinduced gastric lesions. The mechanism by which this occurs remains unknown.
机译:参考文献(21)引用(46)NC-1300(10-100 mg / kg),口服在HCl,乙醇之前的0.5、6、12或24小时,剂量依赖性地保护了大鼠胃粘膜。即使在使用HCl·乙醇之前除去胃内容物,也能观察到这种保护作用。腹膜内给予的NC-1300(30mg / kg)对病变形成没有影响,该剂量有效地抑制了幽门结扎大鼠的胃酸分泌。用吲哚美辛(5 mg / kg,皮下注射)进行预处理不会导致NC-1300的保护作用降低,但内源性前列腺素可能参与了保护机制。 N-乙基马来酰亚胺预处理(10 mg / kg,s.c.)稍微降低了NC-1300的保护活性,表明内源巯基化合物部分参与了NC-1300的保护。口服时,NC-1300硫化物和巯基苯并咪唑(NC-1300与酸性溶液混合后得到的化合物)也剂量依赖性地保护免受HCl·乙醇诱导的损害。在HCl·乙醇之前的0.5小时内。事先给予化合物12小时的保护作用与NC-1300相比,保护作用显着,但大大降低了。 NC-1300砜对病变的形成没有影响。口服奥美拉唑(10,30 mg / kg),也可剂量依赖性地抑制HCl-乙醇诱导的损伤。然而,保护的持续时间比NC-1300所见的要短,即该作用在12小时后消失。因此,NC-1300对HCl·乙醇诱导的胃部病变具有有效而持久的活性。发生这种情况的机制仍然未知。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号